Literature DB >> 11838849

Novel genetic association of Wegener's granulomatosis with the interleukin 10 gene.

Yihua Zhou1, Ricardo Giscombe, Deren Huang, Ann Kari Lefvert.   

Abstract

OBJECTIVE: Wegener's granulomatosis (WG) is a necrotizing vasculitis characterized by clonal expansions of T cells and production of antibodies against proteinase 3. The disease is associated with expanded dinucleotide repeats in the cytotoxic T lymphocyte antigen 4 (CTLA-4) gene, suggesting that genetic variation(s) in T cell related gene(s) could contribute to the T cell hyperactivity in WG. We investigated the polymorphisms in the genes of 2 cytokines, interleukin 4 (IL-4) and IL-10, which are essential for the polarization of T cells towards Th2 development and for the Ig production by B cells.
METHODS: Polymorphisms in the genes coding for IL-10 and IL-4 were analyzed in 32-36 Swedish Caucasian patients and 109 ethnically matched healthy individuals.
RESULTS: There was no association with the IL-4 gene. A CA repeat polymorphism in IL-10 gene, IL-10.G, was associated with the disease. This polymorphism has earlier been associated with high autoantibody production.
CONCLUSION: Our results indicate that the IL-10 gene may influence the disease, perhaps by influencing the production of autoantibodies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11838849

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  12 in total

Review 1.  Genetics of ANCA-associated Vasculitides.

Authors:  Manuel F Ugarte-Gil; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2014-07       Impact factor: 4.592

2.  Patients with Wegener's granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells.

Authors:  Matthew D Morgan; Clara J Day; Karen P Piper; Naeem Khan; Lorraine Harper; Paul A Moss; Caroline O S Savage
Journal:  Immunology       Date:  2010-01-27       Impact factor: 7.397

3.  Distinct tumour necrosis factor alpha, interferon gamma, interleukin 10, and cytotoxic T cell antigen 4 gene polymorphisms in disease occurrence and end stage renal disease in Wegener's granulomatosis.

Authors:  B M Spriewald; O Witzke; R Wassmuth; R R Wenzel; M-L Arnold; T Philipp; J R Kalden
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

Review 4.  Epidemiology and genetics of granulomatosis with polyangiitis.

Authors:  Pratibha Banerjee; Arushi Jain; Uma Kumar; Sabyasachi Senapati
Journal:  Rheumatol Int       Date:  2021-10-11       Impact factor: 2.631

Review 5.  The contribution of genetic variation and infection to the pathogenesis of ANCA-associated systemic vasculitis.

Authors:  Lisa C Willcocks; Paul A Lyons; Andrew J Rees; Kenneth G C Smith
Journal:  Arthritis Res Ther       Date:  2010-02-15       Impact factor: 5.156

Review 6.  Anti-neutrophil cytoplasmic (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies in necrotizing and crescentic glomerulonephritis.

Authors:  Sofia Lionaki; J Charles Jennette; Ronald J Falk
Journal:  Semin Immunopathol       Date:  2007-10-18       Impact factor: 9.623

Review 7.  Wegener's granulomatosis: a model of auto-antibodies in mucosal autoimmunity.

Authors:  James M Kelley; Jeffrey C Edberg; Robert P Kimberly
Journal:  Clin Immunol       Date:  2009-05-23       Impact factor: 3.969

Review 8.  Factor VIII inhibitors: risk factors and methods for prevention and immune modulation.

Authors:  Ai Hong Zhang; Jonathan Skupsky; David W Scott
Journal:  Clin Rev Allergy Immunol       Date:  2009-10       Impact factor: 8.667

Review 9.  Advances in the genomics of ANCA-associated vasculitis-a view from East Asia.

Authors:  Aya Kawasaki; Naoyuki Tsuchiya
Journal:  Genes Immun       Date:  2021-03-08       Impact factor: 2.676

10.  High basal activity of the PTPN22 gain-of-function variant blunts leukocyte responsiveness negatively affecting IL-10 production in ANCA vasculitis.

Authors:  Yali Cao; Jiajin Yang; Kerry Colby; Susan L Hogan; Yichun Hu; Caroline E Jennette; Elisabeth A Berg; Youkang Zhang; J Charles Jennette; Ronald J Falk; Gloria A Preston
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.